checkAd

     207  0 Kommentare REPEAT - Champignon Appoints Dr. Bill Wilkerson, Executive Chairman of Mental Health International to Board of Directors - Seite 2

    Dr. Roger McIntyre, Chief Executive Officer of Champignon, commented: “We are thrilled to welcome Dr. Wilkerson to our board of directors. I look forward to working with him on a personal level as his decades of thought leadership in mental health and extensive global network will be vital to guiding our strategic initiatives and driving operational growth. As we forge a path forward, Dr. Wilkerson’s counsel and expertise will strengthen our mission-critical solutions to better serve our patients along with our employees and shareholders. I am a strong believer that the best processes have a people-centric vision front of mind. Dr. Wilkerson’s years of steadfast diligence and empathy in this space are a valued contribution to our efforts overall.”

    The Company also announces the resignation of Mr. Joe Perino from its board of directors. Champignon thanks Mr. Perino for his contributions to date and wishes him the best of luck with his future endeavours.

    About Champignon Brands Inc.

    Champignon Brands (CSE: SHRM) is focused on the formulation and manufacturing of novel ketamine, anaesthetics, and adaptogenic delivery platforms for nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami's Miller School of Medicine, the Company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability as its medicinal mushroom-infused SKUs are organic, non-GMO, and vegan certified. For more information, visit the Company’s website at: https://champignonbrands.com/.

    ON BEHALF OF THE BOARD OF DIRECTORS

    Dr. Roger McIntyre
    Chief Executive Officer
    E: info@champignonbrands.com

    FOR INVESTOR INQUIRIES:

    Lesen Sie auch

    Tyler Troup
    Circadian Group
    E: SHRM@champignonbrands.com

    Storyboard Communications
    T: +1 (833) 375-9995

    FOR CHAMPIGNON BRANDS FRENCH INQUIRIES:

    Remy Scalabrini
    Maricom Inc.
    E: rs@maricom.ca
    T: (888) 585-MARI

    The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.

    Seite 2 von 4



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    REPEAT - Champignon Appoints Dr. Bill Wilkerson, Executive Chairman of Mental Health International to Board of Directors - Seite 2 VANCOUVER, British Columbia, May 25, 2020 (GLOBE NEWSWIRE) - Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, …